Medicare Enrolled
Dr. Angelo Illuzzi, DO
Pulmonary Disease · Du Bois, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Illuzzi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Illuzzi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Illuzzi
Dr. Angelo Illuzzi is a pulmonary disease specialist in Du Bois, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Illuzzi performed 1,191 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Illuzzi received a total of $6,899 from 46 pharmaceutical and/or device companies across 361 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Illuzzi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 23% volume in PA
$6,899 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,191
Medicare services
Top 23% in PA for pulmonary disease
Not available
Unique patients (not deduplicated)
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
361 | $43 | $68 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
205 | $67 | $100 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
151 | $7 | $40 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
109 | $6 | $37 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
107 | $8 | $37 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
100 | $30 | $348 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
52 | $82 | $450 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
33 | $55 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $100 | $136 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
15 | $86 | $420 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
13 | $16 | $50 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
13 | $32 | $130 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
11 | $39 | $75 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$6,899
Total received (2018-2024)
Avg $986/year across 7 years
Top 24% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
361
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,611
2023
$1,375
2022
$1,149
2021
$690
2020
$425
2019
$675
2018
$972
Payments by company (2024)
GENZYME CORPORATION
$339
Inspire Medical Systems, Inc.
$188
HARMONY BIOSCIENCES LLC
$146
GlaxoSmithKline, LLC.
$143
AstraZeneca Pharmaceuticals LP
$114
INTUITIVE SURGICAL, INC.
$101
SANOFI-AVENTIS U.S. LLC
$79
Avadel CNS Pharmaceuticals, LLC
$61
United Therapeutics Corporation
$59
JAZZ PHARMACEUTICALS INC.
$35
Regeneron Healthcare Solutions, Inc.
$33
Resmed Corp
$32
Axsome Therapeutics, Inc.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
ABBVIE INC.
$24
Philips North America LLC
$24
Mallinckrodt Hospital Products Inc.
$22
ZOLL Respicardia, Inc.
$21
Pharming Healthcare, Inc.
$20
Amgen Inc.
$19
Actelion Pharmaceuticals US, Inc.
$18
Insmed, Inc.
$18
Baxter Healthcare
$17
PFIZER INC.
$16
Grifols USA, LLC
$14
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$9
Top 3 companies account for 41.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$740
GlaxoSmithKline, LLC.
$728
Actelion Pharmaceuticals US, Inc.
$719
GENZYME CORPORATION
$600
Boehringer Ingelheim Pharmaceuticals, Inc.
$372
Inspire Medical Systems, Inc.
$358
JAZZ PHARMACEUTICALS INC.
$280
Regeneron Healthcare Solutions, Inc.
$252
Philips Electronics North America Corporation
$248
HARMONY BIOSCIENCES LLC
$187
PFIZER INC.
$180
SANOFI-AVENTIS U.S. LLC
$179
Harmony Biosciences LLC
$175
Resmed Corp
$148
Grifols USA, LLC
$134
Mylan Specialty L.P.
$133
Janssen Pharmaceuticals, Inc
$114
Axsome Therapeutics, Inc.
$107
INTUITIVE SURGICAL, INC.
$101
Circassia Pharmaceuticals Inc
$93
Baxter Healthcare
$87
Sunovion Pharmaceuticals Inc.
$86
Insmed, Inc.
$85
Takeda Pharmaceuticals U.S.A., Inc.
$78
Amgen Inc.
$75
Novartis Pharmaceuticals Corporation
$73
Gilead Sciences, Inc.
$67
Avadel CNS Pharmaceuticals, LLC
$61
United Therapeutics Corporation
$59
Jazz Pharmaceuticals Inc.
$53
Merck Sharp & Dohme LLC
$32
Haemonetics Corporation
$31
Paratek Pharmaceuticals, Inc.
$26
ABBVIE INC.
$24
Philips North America LLC
$24
Mallinckrodt Hospital Products Inc.
$22
ZOLL Respicardia, Inc.
$21
E.R. Squibb & Sons, L.L.C.
$21
Pharming Healthcare, Inc.
$20
ADVANCED RESPIRATORY, INC
$19
Otsuka America Pharmaceutical, Inc.
$17
Advanced Respiratory, Inc
$16
Merck Sharp & Dohme Corporation
$16
Exeltis, USA Inc.
$16
Mallinckrodt LLC
$12
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$9
Top 3 companies account for 31.7% of all-time payments
Associated products mentioned in payments ›
(2535) Sleep Service · (8744) Trilogy Evo · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · ASMANEX · Arikayce · Astral · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · CHANTIX · DIFICID · DUPIXENT · Da Vinci Surgical System · DreamWear Full · ELIQUIS · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INSPIRE · Inspire Upper Airway Stimulation System · LONHALA MAGNAIR · LUMRYZ · LifeVest · NUCALA · NUZYRA · OFEV · OPDIVO · OPSUMIT · OPSUMIT MACITENTAN · PREVNAR - 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Prolastin-C · Prolastin-C Liquid · RUCONEST · SAMSCA · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEFLARO · TEG · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · WAKIX · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · XYWAV · Xyrem · YUPELRI · Yupelri · remede System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
3
County median income
$60,181
Nearest hospital to ZIP centroid (approximate)
PENN HIGHLANDS DUBOIS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Illuzzi is a clinical cardiology specialist, with above-average Medicare volume (top 23% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Illuzzi experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Illuzzi performed 361 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Illuzzi receive payments from pharmaceutical companies?
Yes. Dr. Illuzzi received a total of $6,899 from 46 companies across 361 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Illuzzi's costs compare to other pulmonary diseases in Du Bois?
Dr. Illuzzi's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Illuzzi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Du Bois
Browse pulmonary diseases in Du Bois ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in PA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in PA
Which PA pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology